Projecting the impact of triple CFTR modulator therapy on intravenous antibiotic requirements in cystic fibrosis using patient registry data combined with treatment effects from randomised trials (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/thoraxjnl-2020-216265

PubMed Identifier: 34556554

Publication URI: http://europepmc.org/abstract/MED/34556554

Type: Journal Article/Review

Parent Publication: Thorax

Issue: 9

ISSN: 0040-6376